S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

Pfizer News Headlines

$41.49
-0.18 (-0.43 %)
(As of 10/15/2021 04:00 PM ET)
Add
Compare
Today's Range
$41.38
$42.03
50-Day Range
$41.42
$50.42
52-Week Range
$33.36
$51.86
Volume23.53 million shs
Average Volume30.12 million shs
Market Capitalization$232.62 billion
P/E Ratio17.81
Dividend Yield3.74%
Beta0.74

Media Mentions By Week

Pfizer Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PFE
News Sentiment

0.29

0.31

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PFE Articles
This Week

57

86

PFE Articles
Average Week

Get Pfizer News Delivered to You Automatically

Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.

Pfizer (NYSE PFE) News Headlines Today

SourceHeadline
marketbeat.com logoThe Latest: Nevada concerned by rural vaccination rates
marketbeat.com - October 15 at 4:23 PM
marketbeat.com logoThe Latest: Court rejects challenge to Maine shot mandate
marketbeat.com - October 15 at 3:31 PM
marketbeat.com logoFDA panel endorses booster shot for J&J COVID-19 vaccine
marketbeat.com - October 15 at 1:49 PM
marketbeat.com logoThe Latest: Judge upholds vaccine mandate for Los Alamos lab
marketbeat.com - October 15 at 12:45 PM
marketbeat.com logoThe Latest: Pfizer seeks European OK for child vaccines
marketbeat.com - October 15 at 11:21 AM
marketbeat.com logoPfizer-BioNTech ask EU agency to OK vaccine for kids 5-11
marketbeat.com - October 15 at 11:06 AM
marketbeat.com logoThe Latest: US to end travel rules for vaccinated on Nov. 8
marketbeat.com - October 15 at 9:56 AM
marketbeat.com logoThe Latest: France requires unvaccinated to pay for tests
marketbeat.com - October 15 at 6:59 AM
marketbeat.com logoThe Latest: UK lab suspended over false negative COVID tests
marketbeat.com - October 15 at 5:48 AM
marketbeat.com logoThe Latest: Sri Lanka begins vaccinating 18-19 age group
marketbeat.com - October 15 at 3:09 AM
marketbeat.com logoThe Latest: Australia's capital: 99% with at least 1 dose
marketbeat.com - October 14 at 9:44 PM
marketbeat.com logoThe Latest: Washington to require shot or test for events
marketbeat.com - October 14 at 7:09 PM
marketbeat.com logoThe Latest: FDA recommends lower-dose Moderna booster shot
marketbeat.com - October 14 at 4:10 PM
marketbeat.com logoThe Latest: FDA likely to rule on virus pill in December
marketbeat.com - October 14 at 3:22 PM
marketbeat.com logoFDA unlikely to rule on Merck's COVID pill before December
marketbeat.com - October 14 at 1:59 PM
marketbeat.com logoFDA grapples with timing of booster for J&J COVID-19 vaccine
marketbeat.com - October 13 at 11:57 AM
marketbeat.com logoThe Latest: FDA considers boosters of Moderna, J&J vaccines
marketbeat.com - October 12 at 10:41 AM
marketbeat.com logoMorgan Stanley Boosts Pfizer (NYSE:PFE) Price Target to $48.00
marketbeat.com - October 12 at 9:21 AM
marketbeat.com logoNext on FDA's agenda: Booster shots of Moderna, J&J vaccines
marketbeat.com - October 12 at 8:15 AM
marketbeat.com logoThe Latest: UN chief decries pandemic's harm to the poor
marketbeat.com - October 11 at 8:10 PM
fool.com logoEurope Recommends Pfizer Boosters for Ages 18 and Up: Could the U.S. Soon Follow? - Motley Fool
fool.com - October 16 at 9:15 AM
nasdaq.com logoBetter COVID-19 Stock: Merck or Pfizer? - Nasdaq
nasdaq.com - October 16 at 9:15 AM
finance.yahoo.com logoEurope Recommends Pfizer Boosters for Ages 18 and Up: Could the U.S. Soon Follow?
finance.yahoo.com - October 16 at 9:15 AM
reuters.com logoS.Africa to vaccinate teenagers with single dose of Pfizer -health minister - Reuters
reuters.com - October 15 at 6:11 PM
abcnews.go.com logoThe Latest: Judge upholds vaccine mandate for Los Alamos lab - ABC News
abcnews.go.com - October 15 at 1:07 PM
reuters.com logoRussian 'vaccine tourists' travel to Serbia for Pfizer shot - Reuters
reuters.com - October 15 at 1:07 PM
ft.com logoWhy Pfizer has won the Covid vaccine race but isn’t getting credit - Financial Times
ft.com - October 15 at 7:46 AM
bloomberg.com logoAustralia to Consider Pfizer Shot for Children as Young as Five - Bloomberg
bloomberg.com - October 14 at 8:42 PM
reuters.com logoU.S. donates 3.6 million doses of Pfizer COVID-19 vaccines to Nigeria - Reuters
reuters.com - October 14 at 8:42 PM
finance.yahoo.com logoU.S. administers 405.4 mln doses of COVID-19 vaccines - CDC
finance.yahoo.com - October 14 at 8:42 PM
fool.com logoPfizer Just Scored Another Key Regulatory Approval - Motley Fool
fool.com - October 14 at 3:41 PM
cnbc.com logoJ&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests
cnbc.com - October 13 at 2:54 PM
reuters.com logoPanama approves Pfizer COVID-19 booster for high-risk people - Reuters
reuters.com - October 13 at 12:50 AM
fool.com logoHow Could Pfizer Be Affected by Moderna's Vaccine Safety Issues? - Motley Fool
fool.com - October 12 at 2:50 PM
MarketBeat logoPfizer (NYSE:PFE) PT Raised to $48.00
americanbankingnews.com - October 12 at 9:56 AM
fool.com logo4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill - The Motley Fool
fool.com - October 11 at 7:08 PM
seekingalpha.com logoIs Pfizer Stock A Buy Or Sell After Booster Shot Authorization? - Seeking Alpha
seekingalpha.com - October 11 at 7:08 PM
nasdaq.com logo4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill - Nasdaq
nasdaq.com - October 11 at 9:07 AM
finance.yahoo.com logo4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill
finance.yahoo.com - October 11 at 9:07 AM
wsj.com logoPfizer-BioNTech Covid-19 Vaccine Is World's Preferred Shot
wsj.com - October 11 at 8:59 AM
nytimes.com logoPfizer to Vaccinate Entire City of Toledo in Brazil As Part of Study - The New York Times
nytimes.com - October 10 at 12:38 PM
fool.com logoWhy Pfizer Will Profit From Merck's Rival Pneumococcal Vaccine - The Motley Fool
fool.com - October 9 at 8:28 PM
cnn.com logoIs my immunity waning? Doctors advise Pfizer vaccine recipients not to worry - CNN
cnn.com - October 9 at 8:28 PM
finance.yahoo.com logoU.S. administers nearly 402 mln COVID-19 vaccine doses, CDC says
finance.yahoo.com - October 9 at 3:27 PM
reuters.com logoBrazil in talks to buy up to 150 mln Pfizer COVID-19 vaccines for 2022 - Reuters Canada
reuters.com - October 9 at 10:27 AM
fool.com logoBetter Bet on COVID Pills: Merck or Pfizer? - Motley Fool
fool.com - October 9 at 10:27 AM
finance.yahoo.com logoU.S. administers more than 400 mln doses of COVID-19 vaccines - CDC
finance.yahoo.com - October 8 at 6:26 PM
finance.yahoo.com logoItaly widens COVID-19 vaccine booster campaign to frail and over 60s
finance.yahoo.com - October 8 at 6:26 PM
seekingalpha.com logoCDC advisory panel to meet November 2-3 to discuss Pfizer COVID vaccine for kids
seekingalpha.com - October 8 at 3:28 PM
bloomberg.com logoPfizer Shot for Kids Moves Closer; Heart Damage: Virus Update - Bloomberg
bloomberg.com - October 8 at 1:23 PM
bloomberg.com logoMalaysia Grants Conditional Approval For Pfizer Booster Shot - Bloomberg
bloomberg.com - October 8 at 1:23 PM
nytimes.com logoDebt Ceiling, Pfizer, Nobel Prize: Your Thursday Evening Briefing - The New York Times
nytimes.com - October 8 at 8:22 AM
marketwatch.com logo: Can children get a flu shot and COVID vaccine at the same time? Here’s what doctors say
marketwatch.com - October 8 at 6:01 AM
fool.com logoCould Pfizer's COVID Pill Be Better Than Merck's? - Motley Fool
fool.com - October 7 at 7:51 PM
nbcnews.com logoHeart risks rare after Pfizer Covid vaccination, study finds - NBC News
nbcnews.com - October 7 at 2:47 PM
feeds.marketwatch.com logoPfizer and BioNTech ask FDA to authorize COVID vaccine for 5- to 11-year-olds
feeds.marketwatch.com - October 7 at 12:31 PM
cnbc.com logoPfizer asks FDA to authorize Covid vaccine for kids ages 5 to 11
cnbc.com - October 7 at 11:57 AM
wsj.com logoPfizer Asks FDA to Authorize Covid-19 Vaccine in Young Children
wsj.com - October 7 at 11:26 AM
reuters.com logoPfizer vaccine for children may be ready by Thanksgiving -White House adviser - Reuters
reuters.com - October 7 at 9:47 AM
nytimes.com logoPfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11 - The New York Times
nytimes.com - October 7 at 9:47 AM
ft.com logoLatest news updates: Pfizer seeks US approval to use Covid jab on children aged 5-12
ft.com - October 7 at 9:10 AM
fool.com logoMerck May Beat Pfizer to the COVID Pill Market. Does It Matter? - Motley Fool
fool.com - October 6 at 1:55 PM
reuters.com logoKazakhstan to buy 4 mln doses of Pfizer COVID-19 vaccine - Reuters
reuters.com - October 6 at 1:55 PM
reuters.com logoPfizer study to vaccinate whole Brazilian town against COVID-19 - Reuters
reuters.com - October 6 at 1:55 PM
nytimes.com logoStudy: Pfizer Vaccine Protects Against Hospitalization for Six Months - The New York Times
nytimes.com - October 6 at 1:55 PM
cnbc.com logoDr. Gottlieb sees Covid’s ‘pandemic phase’ ending when antiviral pills, kids' vaccines available
cnbc.com - October 6 at 1:28 PM
finance.yahoo.com logoNIH Chief Francis Collins to resign, AstraZeneca seeks COVID treatment authorization
finance.yahoo.com - October 5 at 10:39 AM
fool.com logoWhich COVID-19 Pill Stock Is the Best Buy?
fool.com - October 5 at 10:11 AM
cnbc.com logoPfizer Covid shot protects people from hospitalization even as effectiveness against infection falls, Lancet study confirms
cnbc.com - October 4 at 6:54 PM
finance.yahoo.com logoWhy Merck's Covid Pill Is Shaking Vaccine Stocks Even As Boosters Launch
finance.yahoo.com - October 4 at 2:38 PM
Get Pfizer News Delivered to You Automatically

Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.